Concizumab

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B.

Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B.

Journal: The Cochrane database of systematic reviews

Published: March 24, 2026

Comparative Efficacy and Safety of Non-Clotting Factor Prophylaxis Versus. on-Demand Therapy in Hemophilia: A Meta-Analysis of Randomized Controlled Trials.

Comparative Efficacy and Safety of Non-Clotting Factor Prophylaxis Versus. on-Demand Therapy in Hemophilia: A Meta-Analysis of Randomized Controlled Trials.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: March 03, 2026

Challenges in Balancing Hemostasis and Thrombosis in Therapy Tailoring for Hemophilia: A Narrative Review.

Challenges in Balancing Hemostasis and Thrombosis in Therapy Tailoring for Hemophilia: A Narrative Review.

Journal: International journal of molecular sciences

Published: November 26, 2025

Concizumab in hemophilia with inhibitors: longer-term efficacy and safety results from the phase 3 explorer7 study.

Concizumab in hemophilia with inhibitors: longer-term efficacy and safety results from the phase 3 explorer7 study.

Journal: Blood advances

Published: September 03, 2025

Concizumab in hemophilia with inhibitors: Longer-term efficacy and safety results from the phase 3 explorer7 study.

Concizumab in hemophilia with inhibitors: Longer-term efficacy and safety results from the phase 3 explorer7 study.

Journal: Blood advances

Published: September 03, 2025

Concizumab use in toddlers with hemophilia B and inhibitors real-world data from an international collaboration.

Concizumab use in toddlers with hemophilia B and inhibitors real-world data from an international collaboration.

Journal: Journal of thrombosis and haemostasis : JTH

Published: July 15, 2025

Rebalancing therapy for congenital hemophilia

Rebalancing therapy for congenital hemophilia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: July 06, 2025

Curative Therapies for Hemophilias and Hemoglobinopathies in Adults: Immune, Gene, and Stem Cell Approaches in a Global Context.

Curative Therapies for Hemophilias and Hemoglobinopathies in Adults: Immune, Gene, and Stem Cell Approaches in a Global Context.

Journal: Biomedicines

Published: July 06, 2025

Fitusiran (Qfitlia) for hemophilia A and B.

Fitusiran (Qfitlia) for hemophilia A and B.

Journal: The Medical letter on drugs and therapeutics

Published: July 02, 2025

Pharmacokinetic evaluation of concizumab for the treatment of hemophilia.

Pharmacokinetic evaluation of concizumab for the treatment of hemophilia.

Journal: Expert opinion on drug metabolism & toxicology

Published: June 23, 2025

Investigation of the Suitability of the ROTEM Assay to Measure Coagulation Potential in Blood From Patients on Concizumab Prophylaxis.

Investigation of the Suitability of the ROTEM Assay to Measure Coagulation Potential in Blood From Patients on Concizumab Prophylaxis.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: June 20, 2025

Anti-tissue factor pathway inhibitors for hemophilia: are these treatments the answer to overcoming current treatment limitations?

Anti-tissue factor pathway inhibitors for hemophilia: are these treatments the answer to overcoming current treatment limitations?

Journal: Expert review of hematology

Published: June 14, 2025

Showing 1-12 of 80

Last Updated: 04/28/2026